Nalan Alan Selçuk - Concepedia

Author

Nalan Alan Selçuk

Also Known As

Alan Nalan Selçuk, N A Selcuk, N. Alan Selcuk, Nalan A Selcuk, Nalan A. Selcuk, Nalan Alan, Nalan Alan Selcuk, Nalan Alan Selçuk, Nalan Alan Sel�uk, Nalan Alan-Selcuk

Publications

476

Citations

H-Index

Concepts

All Affiliations

Yeditepe University Istanbul University Istanbul University-Cerrahpaşa Şişli Etfal Eğitim ve Araştırma Hastanesi GTx (United States)

About

Nalan Alan Selçuk is an author at Yeditepe University specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	92
2	Health Sciences	2	2	53
3	Pathology	1	1	39
4	Medical Imaging	1	1	23
5	Cancer Research	1	1	39

Nalan Alan Selçuk

Publications

380

Citations

H-Index

Page 1

	Year	Citations
Lu-177-PSMA-617 Prostate-Specific Membrane Antigen Inhibitor Therapy in Patients with Castration-Resistant Prostate Cancer: Stability, Bio-distribution and Dosimetry Levent Kabasakal, Türkay Toklu, Nami Yeyin, Molecular Imaging and Radionuclide Therapy	2017	79
177Lu-DOTATATE therapy in patients with neuroendocrine tumours including high-grade (WHO G3) neuroendocrine tumours Emre Demirci, Levent Kabasakal, Türkay Toklu, Nuclear Medicine Communications	2018	61
Treatment of iodine-negative thyroglobulin-positive thyroid cancer: differences in outcome in patients with macrometastases and patients with micrometastases Levent Kabasakal, Nalan Alan Selçuk, Hojjet Shafipour, European Journal of Nuclear Medicine and Molecular Imaging MedicineThyroid DiseasePathologyThyroid HormoneOncology	2004	39
Clinical Experience with [<sup>225</sup>Ac]Ac-PSMA Treatment in Patients with [<sup>177</sup>Lu]Lu-PSMA–Refractory Metastatic Castration-Resistant Prostate Cancer Nalan Alan Selçuk, Gamze Beydağı, Emre Demirci, Journal of Nuclear Medicine	2023	31
Post-therapy imaging of 225Ac-DOTATATE treatment in a patient with recurrent neuroendocrine tumor Meltem Ocak, Türkay Toklu, Emre Demirci, European Journal of Nuclear Medicine and Molecular Imaging Oncologic ImagingRecurrent Neuroendocrine TumorMedicineNeuroendocrine DisorderPost-therapy Imaging	2020	30
Interobserver and intraobserver agreement on prostate-specific membrane antigen PET/CT images according to the miTNM and PSMA-RADS criteria Emre Demirci, Reşit Akyel, Biray Caner, Nuclear Medicine Communications	2020	24
Prediction of clinically significant prostate cancer by [68 Ga]Ga-PSMA-11 PET/CT: a potential tool for selecting patients for active surveillance Kaan Akçay, Ali Kibar, Onur Erdem Şahin, European Journal of Nuclear Medicine and Molecular Imaging Significant Prostate CancerUrologyHealth SciencesMedical ImagingCancer Detection	2023	23
Initial Findings on the Use of [<sup>225</sup>Ac]Ac-DOTATATE Therapy as a Theranostic Application in Patients with Neuroendocrine Tumors Emre Demirci, Nalan Alan Selçuk, Gamze Beydağı, Molecular Imaging and Radionuclide Therapy	2023	21
Comparison of Metabolic and Anatomic Response to Chemotherapy Based on PERCIST and RECIST in Patients with Advanced Stage Non-small Cell Lung Cancer Nalan Alan Selçuk, Cengiz Akosman, Orhan Önder Eren, Asian Pacific Journal of Cancer Prevention	2015	13
The anti-inflammatory effect of low-level laser therapy on experimentally induced inflammation of rabbit temporomandibular joint retrodiscal tissues. Koray Oral, Nalan Alan Selçuk, Türkay Toklu, PubMed	2010	12

Page 1